Subsection (5)(k) shall now read as follows:
(k) Ketorolac tromethamine – 0.4%, 0.5%;
Subsection (6)(h) is being added and shall now read as follows:
(h) Bepotastine besilate – 1.5%
Subsection (7) shall now read as follows:
(7) ANTIVIRAL AGENTS
(a) Trifluridine – 1.0%.
(b) Ganciclovir – 0.15%.
NAME OF PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Joe Baker, Jr., Executive Director, Board of Optometry/MQA, 4052 Bald Cypress Way, Bin #C07, Tallahassee, FL 32399